1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline

1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline is a synthetic small molecule belonging to the isoquinolines and derivatives chemical class. It features an isoquinoline core substituted with bromine, chlorine, and methoxy groups. The compound is primarily of research interest and is known to target mitogen-activated protein kinase 10 (MAPK10), also known as c-Jun N-terminal kinase 3 (JNK3). Its mechanism of action involves modulation or inhibition of MAPK10 activity; however, detailed pharmacological properties and clinical applications are not established. The compound is classified as experimental and does not have approved therapeutic indications[1][6].

Other names

1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline